Original Research

Is ramucirumab and paclitaxel therapy beneficial for second-line treatment of metastatic gastric or junctional adenocarcinoma for patients with ascites? Analysis of RAINBOW phase 3 trial data

Muro K, Jen MH, Cheng R

Cancer Management and Research 2019, 11:2261-2267

Published Date: 20 March 2019